NEW PUBLICATION!!

ProAlgaZyme™ cholesterol management potential

Breaking News, December 19, 2009

HEPI is focused on isolating and identifying the active cholesterol agents
present in PAZ. A study conducted during summer 2009 at Wayne State
University’s Department of Nutrition and Food Science by Dr. Smiti Gupta
demonstrated unequivocally that PAZ filtrates are able to lower LDL
cholesterol while raising HDL cholesterol in animal subjects. This bolsters
previous studies that indicated similar results in humans and animals,
albeit not under the strict conditions imposed by the
Wayne State University study.

Full Report Here

---

Health Enhancement Products, Inc. is pleased to announce
the recent publication of a clinical trial investigating
the effects of ProAlgaZyme on Metabolic Syndrome and
markers of cardiovascular health.

Click to read summary:
http://www.lipidworld.com/content/6/1/20

You may also download the full article as a PDF file with color graphs:
http://www.lipidworld.com/content/pdf/1476-511x-6-20.pdf

The article was published in Lipids in Health and Disease,
a free open-access journal in the BioMed Central network of journals.

Another clinical trial recently completed
investigated the effects of ProAlgaZyme and Immune Health.
The results of this study have been submitted for peer-reviewed publication.

We hope to announce our second publication
by the end of 2007!

 

Thank you for your interest in ProAlgaZyme Algae Infusion.

Read FAQs

View Product Brochure        View Quick Fact Sheet

ProAlgaZyme® is available exclusively from
Health Enhancement Products Inc., Scottsdale, AZ

*The statements in this brochure have not been evaluated by the US
Food and Drug Administration. ProAlgaZyme™ is not intended to
diagnose, treat, cure or prevent any disease.